177 related articles for article (PubMed ID: 16307738)
1. Effects of fasudil, a Rho-kinase inhibitor, on myocardial preconditioning in anesthetized rats.
Demiryürek S; Kara AF; Celik A; Babül A; Tarakçioglu M; Demiryürek AT
Eur J Pharmacol; 2005 Dec; 527(1-3):129-40. PubMed ID: 16307738
[TBL] [Abstract][Full Text] [Related]
2. Effects of Y-27632, a selective Rho-kinase inhibitor, on myocardial preconditioning in anesthetized rats.
Demiryürek S; Kara AF; Celik A; Tarakçioğlu M; Bağci C; Demiryürek AT
Biochem Pharmacol; 2005 Jan; 69(1):49-58. PubMed ID: 15588713
[TBL] [Abstract][Full Text] [Related]
3. Effects of chronic trimetazidine treatment on myocardial preconditioning in anesthetized rats.
Kara AF; Demiryürek S; Celik A; Tarakçioğlu M; Demiryürek AT
Fundam Clin Pharmacol; 2006 Oct; 20(5):449-59. PubMed ID: 16968415
[TBL] [Abstract][Full Text] [Related]
4. Effects of trimetazidine on myocardial preconditioning in anesthetized rats.
Kara AF; Demiryürek S; Celik A; Tarakçioğlu M; Demiryürek AT
Eur J Pharmacol; 2004 Oct; 503(1-3):135-45. PubMed ID: 15496308
[TBL] [Abstract][Full Text] [Related]
5. Acute vasodilator effect of fasudil, a Rho-kinase inhibitor, in monocrotaline-induced pulmonary hypertension in rats.
Jiang BH; Tawara S; Abe K; Takaki A; Fukumoto Y; Shimokawa H
J Cardiovasc Pharmacol; 2007 Feb; 49(2):85-9. PubMed ID: 17312448
[TBL] [Abstract][Full Text] [Related]
6. The potential antiarrhythmic effects of exogenous and endogenous bradykinin in the ischaemic rat heart in vivo.
Sun W; Wainwright CL
Coron Artery Dis; 1994 Jun; 5(6):541-50. PubMed ID: 7952414
[TBL] [Abstract][Full Text] [Related]
7. High-dose fasudil preserves postconditioning against myocardial infarction under hyperglycemia in rats: role of mitochondrial KATP channels.
Ichinomiya T; Cho S; Higashijima U; Matsumoto S; Maekawa T; Sumikawa K
Cardiovasc Diabetol; 2012 Mar; 11():28. PubMed ID: 22436066
[TBL] [Abstract][Full Text] [Related]
8. Long-term inhibition of Rho kinase with fasudil attenuates high flow induced pulmonary artery remodeling in rats.
Li F; Xia W; Li A; Zhao C; Sun R
Pharmacol Res; 2007 Jan; 55(1):64-71. PubMed ID: 17127075
[TBL] [Abstract][Full Text] [Related]
9. N-2-mercaptopropionylglycine, a scavanger of reactive oxygen species, does not modify the early antiarrhythmic effect of ischaemic preconditioning in anaesthetised dogs.
Agnes H; Nagy L; Parratt JR; Papp J; Végh A
Cardiovasc Drugs Ther; 2004 Nov; 18(6):449-59. PubMed ID: 15770432
[TBL] [Abstract][Full Text] [Related]
10. Anti-ischemic effects of fasudil, a specific Rho-kinase inhibitor, in patients with stable effort angina.
Fukumoto Y; Mohri M; Inokuchi K; Ito A; Hirakawa Y; Masumoto A; Hirooka Y; Takeshita A; Shimokawa H
J Cardiovasc Pharmacol; 2007 Mar; 49(3):117-21. PubMed ID: 17414222
[TBL] [Abstract][Full Text] [Related]
11. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina.
Masumoto A; Mohri M; Shimokawa H; Urakami L; Usui M; Takeshita A
Circulation; 2002 Apr; 105(13):1545-7. PubMed ID: 11927519
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient mice.
Wang YX; da Cunha V; Martin-McNulty B; Vincelette J; Li W; Choy DF; Halks-Miller M; Mahmoudi M; Schroeder M; Johns A; Light DR; Dole WP
Eur J Pharmacol; 2005 Apr; 512(2-3):215-22. PubMed ID: 15840407
[TBL] [Abstract][Full Text] [Related]
13. Vasodilator effects of fasudil, a Rho-kinase inhibitor, on retinal arterioles in stroke-prone spontaneously hypertensive rats.
Okamura N; Saito M; Mori A; Sakamoto K; Kametaka S; Nakahara T; Ishii K
J Ocul Pharmacol Ther; 2007 Jun; 23(3):207-12. PubMed ID: 17593003
[TBL] [Abstract][Full Text] [Related]
14. Fasudil, a Rho kinase (ROCK) inhibitor, protects against ischemic neuronal damage in vitro and in vivo by acting directly on neurons.
Yamashita K; Kotani Y; Nakajima Y; Shimazawa M; Yoshimura S; Nakashima S; Iwama T; Hara H
Brain Res; 2007 Jun; 1154():215-24. PubMed ID: 17482584
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological profile of hydroxy fasudil as a selective rho kinase inhibitor on ischemic brain damage.
Satoh S; Utsunomiya T; Tsurui K; Kobayashi T; Ikegaki I; Sasaki Y; Asano T
Life Sci; 2001 Aug; 69(12):1441-53. PubMed ID: 11531167
[TBL] [Abstract][Full Text] [Related]
16. Long-term administration of rho-kinase inhibitor ameliorates renal damage in malignant hypertensive rats.
Ishikawa Y; Nishikimi T; Akimoto K; Ishimura K; Ono H; Matsuoka H
Hypertension; 2006 Jun; 47(6):1075-83. PubMed ID: 16636194
[TBL] [Abstract][Full Text] [Related]
17. Administration of the Rho-kinase inhibitor fasudil before ischemia or just after reperfusion, but not 30 min after reperfusion, protects the stunned myocardium in swine.
Shibata I; Yoshitomi O; Use T; Ureshino H; Cho S; Maekawa T; Hara T; Sumikawa K
Cardiovasc Drugs Ther; 2008 Aug; 22(4):293-8. PubMed ID: 18470606
[TBL] [Abstract][Full Text] [Related]
18. Expression of Rho-kinase (ROCK-1 and ROCK-2) and its substantial role in the contractile activity of the sheep ureter.
Levent A; Büyükafsar K
Br J Pharmacol; 2004 Oct; 143(3):431-7. PubMed ID: 15351780
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Rho-kinase attenuates nephrosclerosis and improves survival in salt-loaded spontaneously hypertensive stroke-prone rats.
Nishikimi T; Koshikawa S; Ishikawa Y; Akimoto K; Inaba C; Ishimura K; Ono H; Matsuoka H
J Hypertens; 2007 May; 25(5):1053-63. PubMed ID: 17414670
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective effects of low-dose combination therapy with rosuvastatin and fasudil in the isolated rat heart.
Wu N; Li W; Lv Y; Shu W; Jia D
Pharmazie; 2014 Sep; 69(9):704-8. PubMed ID: 25272944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
